Ipca Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,388.48 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.17 per cent from ₹2,392.50 crore. This corresponds to a year-on-year *(YoY) growth of 6.31 per cent.
Operating Profit
Operating Profit stands at ₹438.05 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.87 per cent from ₹533.35 crore. This corresponds to a year-on-year *(YoY) growth of 95.72 per cent.
PBDT
PBDT stands at ₹508.88 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.01 per cent from ₹553.19 crore. This corresponds to a year-on-year *(YoY) growth of 124.84 per cent.
Profit Before Tax
Profit Before Tax stands at ₹401.74 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.84 per cent from ₹445.60 crore. This corresponds to a year-on-year *(YoY) growth of 218.31 per cent.
Net Profit
Net Profit stands at ₹306.69 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.67 per cent from ₹363.67 crore. This represents a 379.28 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Ipca Laboratories Ltd News
Ipca Laboratories Ltd Earnings
- YOY
- QOQ
Ipca Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Ipca Laboratories Ltd Research Reports
Ipca Laboratories Ltd Financial Reports
Ipca Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ipca Labs. | 2.40% | 2.15% | 0.70% | 3.35% | 10.51% | 18.21% |
| Glenmark Pharma. | 2.71% | 2.65% | -5.20% | 6.07% | 8.18% | 31.31% |
| Abbott India | 0.04% | 0.51% | -5.35% | 2.94% | -7.48% | -15.66% |
| Anthem Bioscienc | -0.84% | 2.93% | 3.45% | 25.89% | 18.26% | 8.35% |
| Glaxosmi. Pharma | 2.91% | 5.98% | 1.42% | 2.32% | -6.62% | -26.39% |
| Ajanta Pharma | -0.40% | -0.51% | -0.64% | 9.36% | 14.86% | 19.59% |
| Gland Pharma | -0.02% | 0.79% | -5.76% | 36.36% | 30.37% | 26.05% |
Company Info
Company Information
Executive Chairman : Premchand Godha
Managing Director & CFO : A K Jain
Managing Director & Chief Executive Officer : Pranay Godha
Executive Director : Prashant Godha
Independent Non Exe. Director : Kamal Kishore Seth
Independent Non Exe. Director : Narendra Mairpady
Company Sec. & Compli. Officer : Harish P Kamath
Independent Director : Swati Patankar
Independent Director : Vivek Shiralkar